Active Infrastructures' IPO received a subdued response with 1.05x subscription, reflecting a muted GMP of zero ahead of its NSE SME platfo...

Are you looking for some good gadgets to give your loved ones on New Year? Here is a list of smart gadgets and devices that you can conside...

Drug major Sun Pharma has received approval from competition watchdog CCI to sell the erstwhile Ranbaxy Laboratories' two divisions.

Strides Shasun today got CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.

The agreement involves transfer of these two marketing divisions, along with employees to Strides for a consideration of Rs 165 crore.

As part of the deal, India’s largest drug maker Sun Pharma will transfer two arms of Ranbaxy – Solus and Solus care – for a consideration o...

Can multiple celebrity ambassadors add more sheen to a brand? Or is bringing in a pair of fresh legs just a smart strategy in succession pl...

Bharatiya Janata Party first identified its target groups and accordingly designed its advertisement campaigns for the Lok Sabha elections.

A roadblock is when a particular advertiser buys up all the advertising time in the channel for a specific period of time blocking all the ...

The mega Ranbaxy deal will have a trickle-down impact on mid-sized companies Zenotech Labs and Orchid Pharma in which the Delhi-based numbe...

A creeping acquisition has begun in the shares of Chennai-based Orchid Chemicals & Pharmaceuticals which has become vulnerable to acquisiti...

They are the two iconic forces of Indian pop culture. But which one truly captures your imagination?